Abstract
Breast cancer remains the leading cause of cancer-related death among women worldwide, underscoring the urgent need for sensitive and non-invasive diagnostic tools. Cancer stem cells (CSCs), particularly those expressing the CD44 biomarker, play a pivotal role in tumor progression, metastasis, and therapy resistance. In this study, we present the development of a graphene oxide-functionalized, label-free optical fiber biosensor for the ultrasensitive detection of CD44 in biological fluids for breast cancer diagnostics. The sensor utilizes a spliced single-mode fiber with an enhanced backscattering tip to construct a Fabry-Pérot interferometric cavity, enabling precise refractive index interrogation. Surface functionalization involved sequential silanization, glutaraldehyde crosslinking, graphene oxide deposition (chemical and physical), and oriented antibody immobilization using carbodiimide chemistry and Protein G. Calibration with sucrose solutions demonstrated a refractive index sensitivity of 184.5 dB/RIU. Preliminary tests using human urine samples showed promising performance for attomolar-level CD44 detection. Compared to label-based systems, this label-free platform offers simplified fabrication, real-time signal acquisition, and compatibility with minimally processed samples, making it highly suitable for CSC-targeted diagnostics. Overall, the developed biosensor represents a scalable and biocompatible solution for early breast cancer screening and CSC profiling.